OncoCyte ROE 2014-2025 | OCX

Current and historical return on equity (ROE) values for OncoCyte (OCX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
OncoCyte ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.06B $0.01B -761.29%
2024-12-31 $-0.06B $-0.01B -739.39%
2024-09-30 $-0.04B $0.01B -270.77%
2024-06-30 $-0.04B $0.02B -163.44%
2024-03-31 $-0.04B $0.01B -143.86%
2023-12-31 $-0.03B $0.02B -82.86%
2023-09-30 $-0.06B $0.04B -148.05%
2023-06-30 $-0.06B $0.04B -124.35%
2023-03-31 $-0.06B $0.04B -103.45%
2022-12-31 $-0.07B $0.03B -116.33%
2022-09-30 $-0.06B $0.08B -90.78%
2022-06-30 $-0.07B $0.08B -89.47%
2022-03-31 $-0.07B $0.06B -86.42%
2021-12-31 $-0.06B $0.07B -68.45%
2021-09-30 $-0.03B $0.10B -39.77%
2021-06-30 $-0.03B $0.10B -38.85%
2021-03-31 $-0.03B $0.11B -48.37%
2020-12-31 $-0.03B $0.03B -82.76%
2020-09-30 $-0.03B $0.04B -89.51%
2020-06-30 $-0.03B $0.04B -87.59%
2020-03-31 $-0.03B $0.04B -79.39%
2019-12-31 $-0.02B $0.03B -66.67%
2019-09-30 $-0.02B $0.03B -73.08%
2019-06-30 $-0.02B $0.03B -81.93%
2019-03-31 $-0.02B $0.04B -121.43%
2018-12-31 $-0.02B $0.00B -251.85%
2018-09-30 $-0.02B $0.01B -228.57%
2018-06-30 $-0.02B $0.01B -285.71%
2018-03-31 $-0.02B $0.01B -281.48%
2017-12-31 $-0.02B $0.00B -296.30%
2017-09-30 $-0.02B $0.01B -230.30%
2017-06-30 $-0.02B $0.01B -157.89%
2017-03-31 $-0.01B $0.01B -155.56%
2016-12-31 $-0.01B $0.01B -141.18%
2016-09-30 $-0.01B $0.01B -152.94%
2016-06-30 $-0.01B $0.00B -228.57%
2016-03-31 $-0.01B $0.01B -235.29%
2015-12-31 $-0.01B $0.01B -320.00%
Sector Industry Market Cap Revenue
Medical Medical Services $0.098B $0.002B
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.174B 25.17
Elevance Health (ELV) United States $86.874B 11.21
CVS Health (CVS) United States $76.179B 9.47
Cencora (COR) United States $56.230B 19.56
DiDi Global (DIDIY) China $23.297B 35.36
Natera (NTRA) United States $20.821B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.571B 13.31
EUROFINS SCIENT (ERFSF) Luxembourg $12.522B 0.00
CochLear (CHEOY) Australia $11.391B 0.00
Revvity (RVTY) United States $10.665B 18.35
ICON (ICLR) Ireland $10.255B 9.53
Viatris (VTRS) United States $9.976B 3.43
Doximity (DOCS) United States $9.570B 44.57
Avantor (AVTR) United States $8.763B 12.73
HealthEquity (HQY) United States $8.657B 42.59
Medpace Holdings (MEDP) United States $8.422B 22.37
Sonic Healthcare (SKHHY) Australia $8.157B 0.00
Charles River Laboratories (CRL) United States $6.660B 13.05
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $3.994B 36.97
Bausch + Lomb (BLCO) Canada $3.976B 23.44
Sotera Health (SHC) United States $3.480B 19.77
Surgery Partners (SGRY) United States $2.896B 37.67
Alignment Healthcare (ALHC) United States $2.867B 0.00
Concentras Parent (CON) United States $2.744B 15.86
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.117B 9.02
GeneDx Holdings (WGS) United States $1.921B 73.99
Premier (PINC) United States $1.910B 14.50
Progyny (PGNY) United States $1.791B 39.42
PACS (PACS) United States $1.494B 0.00
GoodRx Holdings (GDRX) United States $1.364B 27.29
Teladoc Health (TDOC) United States $1.211B 0.00
Pediatrix Medical (MD) United States $1.200B 9.13
Establishment Labs Holdings (ESTA) $1.066B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.953B 14.88
Agilon Health (AGL) United States $0.911B 0.00
Nutex Health (NUTX) United States $0.901B 13.61
AMN Healthcare Services Inc (AMN) United States $0.830B 7.77
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.614B 4.14
InnovAge Holding (INNV) United States $0.543B 0.00
LifeMD (LFMD) United States $0.523B 0.00
Enhabit (EHAB) United States $0.520B 42.75
Auna S.A (AUNA) Luxembourg $0.505B 11.37
Sonida Senior Living (SNDA) United States $0.465B 0.00
SBC Medicals (SBC) United States $0.398B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.388B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.214B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
So-Young (SY) China $0.088B 0.00
Sera Prognostics (SERA) United States $0.071B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.052B 0.00
Pheton Holdings (PTHL) China $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00